Floatz logo

1,125 assets in Non-Small Cell Lung Carcinoma

Therapeutic assets addressing Non-Small Cell Lung Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
²¹²pb-dotam-grpr1
Non-Small Cell Lung Carcinoma
Orano Med Theranostics, SASP1C (37)
[225Ac]Ac-AKY-1189
Non-Small Cell Lung Carcinoma
Aktis Oncology, Inc.P1C (37)
[64Cu]Cu-AKY-1189
Non-Small Cell Lung Carcinoma
Aktis Oncology, Inc.P1C (37)
[68ga]ga-dwj155
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (37)
ag-01 compound
Non-Small Cell Lung Carcinoma
A&G Pharmaceutical Inc.P1C (37)
ai-061
Non-Small Cell Lung Carcinoma
OncoC4, Inc.P1C (37)
Alpaloritovorelli Antibodies
Non-Small Cell Lung Carcinoma
Anhui Provincial HospitalP1C (37)
Apg 2449
Non-Small Cell Lung Carcinoma
Ascentage Pharma Group Inc.P1C (37)
Arry-558
Non-Small Cell Lung Carcinoma
PfizerP1C (37)
Ast-201
Non-Small Cell Lung Carcinoma
Aptamer Sciences, Inc.P1C (37)
Astx727
Non-Small Cell Lung Carcinoma
Royal Marsden NHS Foundation TrustP1C (37)
aur106
Non-Small Cell Lung Carcinoma
Aurigene Discovery Technologies LimitedP1C (37)
azd1390
Non-Small Cell Lung Carcinoma
University of LeedsP1C (37)
Bl-M17D1
Non-Small Cell Lung Carcinoma
SystImmune Inc.P1C (37)
Bl-M24D1
Non-Small Cell Lung Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P1C (37)
Blu-701
Non-Small Cell Lung Carcinoma
Blueprint Medicines CorporationP1C (37)
Bpi-1178
Non-Small Cell Lung Carcinoma
National Cancer Center, ChinaP1C (37)
Bpi-371153
Non-Small Cell Lung Carcinoma
Betta Pharmaceuticals Co., Ltd.P1C (37)
Clsp-5282
Non-Small Cell Lung Carcinoma
Clasp Therapeutics, Inc.P1C (37)
cs08399
Non-Small Cell Lung Carcinoma
Chipscreen Biosciences, Ltd.P1C (37)
Ctx-8371
Non-Small Cell Lung Carcinoma
Compass TherapeuticsP1C (37)
dk210
Non-Small Cell Lung Carcinoma
DEKA BiosciencesP1C (37)
dky709
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (37)
dm001
Non-Small Cell Lung Carcinoma
Xadcera Biopharmaceutical (Suzhou) Co., Ltd.P1C (37)
dm005
Non-Small Cell Lung Carcinoma
Doma Biopharmaceutical(Suzhou)Co., Ltd.P1C (37)
dr-0202
Non-Small Cell Lung Carcinoma
Dren BioP1C (37)
Emapalumab
Non-Small Cell Lung Carcinoma
Nerissa T. ViolaP1C (37)
Emunkitug
Non-Small Cell Lung Carcinoma
HiFiBiO TherapeuticsP1C (37)
Felmetatug Vedotin
Non-Small Cell Lung Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1C (37)
ft536
Non-Small Cell Lung Carcinoma
Fate TherapeuticsP1C (37)
Hbi-2376
Non-Small Cell Lung Carcinoma
HUYABIO International, LLC.P1C (37)
Hbi-2438
Non-Small Cell Lung Carcinoma
HUYABIO International, LLC.P1C (37)
hc-7366
Non-Small Cell Lung Carcinoma
HiberCell, Inc.P1C (37)
Hekt Cell
Non-Small Cell Lung Carcinoma
Ruijin HospitalP1C (37)
hfb200603
Non-Small Cell Lung Carcinoma
HiFiBiO TherapeuticsP1C (37)
H-Gamma1 Heavy Chain Humanized (1-449) [Vh (Homo Sapiens Ighv3-23*01 (81.6%) -(Ighd) -Ighj3*02 (91.7%) M123>T (114), Cdr-Imgt [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo Sapiens Ighg1*03V (100%) G1M3>G1M17, Ng1M1 Ch1 K120, Ch3 E12, M14 (Ch1 R120>K (216) (120-217), Hinge 1-15 (218-232), Ch2 (233-342), Ch3 E12 (358), M14 (360) (343-447), Chs (448-449)) (120-449)], (222-218')-Disulfide With L-Kappa Light Chain Humanized (1'-218') [Vkappa (Homo Sapiens Igkv1-33*01 (87.8%) -Igkj4*01 (100%), Cdr-Imgt [6.3.13] (27'-32'.50'-52'.89'-101')) (1'-111')-Homo Sapiens Igkc*01 (100%) Km3 A45.1, V101 (C-Kappaa45.1 (157'), V101 (195')) (112'-218')]; Dimer (228-228'':231-231'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Cell Line Cho-K1, Glycoform Alfa
Non-Small Cell Lung Carcinoma
Genentech, Inc.P1C (37)
Honokiol
Non-Small Cell Lung Carcinoma
The Methodist Hospital Research InstituteP1C (37)
hsk40118
Non-Small Cell Lung Carcinoma
Haisco Pharmaceutical Group Co., Ltd.P1C (37)
Humanized Immunoglobulin G1-Kappa Anti-(Human Cd8) Fused At The C-Terminus Of One Heavy Chain, Via Peptide Linker <Sup>449</Sup> Sggggsggggsggggs<Sup>464</Sup>, To A Variant Of Human Interleukin-2, Glycoform Alfa
Non-Small Cell Lung Carcinoma
Asher Biotherapeutics, Inc.P1C (37)
Icovamenib
Non-Small Cell Lung Carcinoma
Biomea Fusion Inc.P1C (37)
ide034
Non-Small Cell Lung Carcinoma
IDEAYA BiosciencesP1C (37)
Ide-161
Non-Small Cell Lung Carcinoma
IDEAYA BiosciencesP1C (37)
Immunoglobulin G1 [De-451-Lysine], Anti-(Human/Macaca Fascicularis/Macaca Mulatta/Chlorocebus Sabaeus Mhc Class I Chain-Related Protein Mica/Mhc Class I Chain-Related Protein Micb) (Human-Mus Musculus Monoclonal Cln-619 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Cln-619 [34-Leucine] ?-Chain, Dimer
Non-Small Cell Lung Carcinoma
Cullinan Therapeutics Inc.P1C (37)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Cldn6 (Claudin 6, Claudin-6)], Monoclonal Antibody (Ixotatug)
Non-Small Cell Lung Carcinoma
TORL Biotherapeutics, LLCP1C (37)
Jnj-86974680
Non-Small Cell Lung Carcinoma
Johnson & Johnson Enterprise Innovation Inc.P1C (37)
Jsi-1187
Non-Small Cell Lung Carcinoma
JS InnoPharm, LLCP1C (37)
kfa115
Non-Small Cell Lung Carcinoma
Novartis PharmaceuticalsP1C (37)
kk2269
Non-Small Cell Lung Carcinoma
Kyowa Kirin Co., Ltd.P1C (37)
Loxo-260
Non-Small Cell Lung Carcinoma
Eli Lilly and CompanyP1C (37)
ly4170156
Non-Small Cell Lung Carcinoma
Eli Lilly and CompanyP1C (37)
Showing 851 to 900 of 1,125 assets
PreviousPage 18 of 23Next